Harbor Tirzepatide Review: Cost, a 12-Month Money-Back Guarantee & Honest Verdict (2026)

Harbor: $149/month for tirzepatide, a genuine LegitScript certification, and the specific self-reported stats (4.7-star rating, 94.6% success rate, 10,000+ members) all present on the site — among the lowest headline prices this site has documented. Every fact here comes from the company's own published program.

What Harbor is

Harbor is a physician-led telehealth platform, offering compounded semaglutide from $99/month and tirzepatide from $149/month — among the lowest headline prices in this category. LegitScript certified, with 24/7 physician access, ongoing consultations, and dosage adjustments included.

What Harbor costs

Tirzepatide starts at $149/month, semaglutide at $99/month, both starting-dose figures. HSA/FSA eligible, with no hidden fees and no insurance billed, plus free discreet shipping.

A real 12-month money-back guarantee

Harbor offers a 12-Month Money Back Guarantee if you don't reach your weight-loss goal — a genuinely long guarantee window compared to most competitors' shorter or nonexistent policies.

Self-reported stats, not third-party verified

Harbor's 4.7-star rating, 94.6% success rate, and 10,000+ verified members all appear prominently on the site. These are on-site claims rather than independently, third-party verified figures — worth knowing the source before weighing them heavily.

The brand-vs-compounded question

Harbor dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Harbor's real strengths: among the lowest headline prices in this category, genuine LegitScript certification, a real 12-month money-back guarantee, 24/7 physician access, and HSA/FSA eligibility with no hidden fees. The trade-offs: this review found no named compounding pharmacy, dietitian support is post-program only (maintenance phase, not during active treatment), nationwide availability isn't confirmed for all states, no labs disclosed, and the patient portal runs through a third-party platform (MDIntegrations) rather than a native one. As with any GLP-1 program, and one with self-reported (not third-party-verified) success stats, confirm your state's coverage directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Harbor's confirmed low pricing, genuine LegitScript certification, and real 12-month money-back guarantee are strong positives, all independently confirmed by this review. Its self-reported success stats are worth treating as marketing claims rather than independently verified figures. For a similarly low-priced provider with a named pharmacy, compare it against BiltRx or Fresh Day Meds. For a provider offering both compounded and brand-name access with a specific LegitScript ID, see HeliMeds. For a provider with a genuinely self-hosted LegitScript badge this review couldn't CDN-verify, see NiceRx. See our best tirzepatide providers ranking for the full field.